Response to a Second Single Antihypertensive Agent Used as Monotherapy for Hypertension After Failure of the Initial Drug

Autor: Barbara Gregory, Karen M. Cooper, William G. Henderson, H. Mitchell Perry, Alba Jimenez, Jose L. Cianchini, Mike R. Sather, Rhonda Sapp, Colleen Stewart, David R. Williams, Patricia Olzinski, Domenic J. Reda, Ping Huang, Richard E. Borreson, Walter M. Kirkendall, Barbara Luzniak, Ray W. Gifford, Mahendr S. Kochar, Larry Monahan, Charlene Arnold, William C. Cushman, Jean Rowe, Claude Foy, Christopher Grant, Martin Henry, Ann Pieczek, Barbara Lizano, Deborah Berg, Elaine Der, Barry M. Massie, Frances Chacon, Rosemary Mannix, Kalman C. Mezey, Ibrahim M. Khatri, Anita McKnight, Mazen Abdellatif, John S. Gottdiener, Barry J. Materson, Eli A. Ramirez, Barbara Mackay, Judy Politte, Edward D. Freis, Aldo Notargiacomo, Richard A. Preston, Daniel Deykin, Carol L. Fye, Julio Tubau, Frederick N. Talmers, Joseph Asch, Raj Lakshman, Dolly Koontz, Kathleen Fox, Clydie Rainey, Mike Tobin, Bangshi Mukherji, Sandra Buchanan, Lois Anne Katz, Mary H. Smith, Dee Trottier, Robert J. Hamburger, Marion Pannone, San Juan, Stewart Nunn, Narain T. Srivastava, Shirley Tir, William H. Gaasch, Robert F. Woolson, Janet Gold, William W. Neal, Peter Coutlakis

Publikováno v: Archives of Internal Medicine. 155:1757

Background: An important issue in clinical practice is how to treat patients whose blood pressure does not respond to the first antihypertensive drug selected. Objective: To analyze the antihypertensive response of patients who had failed to achieve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5c39064a72d3238b25f6f0744214fa1
https://doi.org/10.1001/archinte.1995.00430160089009